{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:16:06Z","timestamp":1762272966201,"version":"3.44.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.chroma.2022.463487","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T11:44:05Z","timestamp":1662551045000},"page":"463487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Design and economic investigation of a Multicolumn Countercurrent Solvent Gradient Purification unit for the separation of an industrially relevant PEGylated protein"],"prefix":"10.1016","volume":"1681","author":[{"given":"Tae Keun","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedetta","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jose","family":"Romero Conde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Angelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuankuo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanchayita","family":"Ghose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Morbidelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia","family":"Sponchioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2022.463487_bib0001","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/biot.200900218","article-title":"PEGylation of therapeutic proteins","volume":"5","author":"Jev\u0161evar","year":"2010","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.chroma.2022.463487_bib0002","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijpharm.2013.06.077","article-title":"Production, purificationand biological characterization of mono-PEGylated anti-IL-17A antibody fragments","volume":"454","author":"Koussoroplis","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chroma.2022.463487_bib0003","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00063030-200822050-00004","article-title":"The impact of PEGylation on biological therapies","volume":"22","author":"Veronese","year":"2008","journal-title":"BioDrugs"},{"key":"10.1016\/j.chroma.2022.463487_bib0004","unstructured":"Biopharma P.E.G., FDA approved PEGylated drugs up to 2022, (2019). https:\/\/www.biochempeg.com\/article\/58.html."},{"issue":"29","key":"10.1016\/j.chroma.2022.463487_bib0005","doi-asserted-by":"crossref","first-page":"10764","DOI":"10.1021\/acs.iecr.1c01345","article-title":"Experimental design of the Multicolumn Countercurrent Solvent Gradient Purification (MCSGP) unit for the separation of PEGylated proteins","volume":"60","author":"Kim","year":"2021","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.chroma.2022.463487_bib0006","unstructured":"P. Jaiswal for Allied Market Research, Global PEGylated protein therapeutics market expected to reach $17,813 million by 2025, Allied Mark. Res. (2018). https:\/\/www.prnewswire.com\/news-releases\/pegylated-protein-therapeutics-market-worth-17-813-million-by-2025-cagr-6-9-allied-market-research-818141033.html."},{"key":"10.1016\/j.chroma.2022.463487_bib0007","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/biot.201200143","article-title":"PEGylated protein separations: challenges and opportunities","volume":"7","author":"Yoshimoto","year":"2012","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.chroma.2022.463487_bib0008","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/978-1-62703-977-2_37","article-title":"Purification of PEGylated proteins, with the example of PEGylated lysozyme and PEGylated scFv","volume":"1129","author":"Moosmann","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.chroma.2022.463487_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/s2175-97902018000001009","article-title":"Protein PEGylation for the design of biobetters: from reaction to purification processes","volume":"54","author":"Santos","year":"2018","journal-title":"Braz. J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2022.463487_bib0010","first-page":"81","article-title":"N-terminal PEGylation of human serum albumin and investigation of its pharmacokinetics and pulmonary microvascular retention","volume":"6","author":"Zhao","year":"2012","journal-title":"Biosci. Trends."},{"key":"10.1016\/j.chroma.2022.463487_bib0011","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jchromb.2015.08.027","article-title":"Effect of lysozyme solid-phase PEGylation on reaction kinetics and isoform distribution","volume":"1002","author":"Maiser","year":"2015","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.chroma.2022.463487_bib0012","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jconrel.2014.02.002","article-title":"Process for protein PEGylation","volume":"180","author":"Pfister","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chroma.2022.463487_bib0013","first-page":"1625","article-title":"From batch to continuous chromatographic purification of a therapeutic peptide through Multicolumn Countercurrent Solvent Gradient Purification","author":"De Luca","year":"2020","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2022.463487_bib0014","doi-asserted-by":"crossref","DOI":"10.1002\/bit.28093","article-title":"Continuous countercurrent chromatographic twin-column purification of oligonucleotides: the role of the displacement effect","author":"Fioretti","year":"2022","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.chroma.2022.463487_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2020.116051","article-title":"Modern trends in downstream processing of biotherapeutics through continuous chromatography: the potential of Multicolumn Countercurrent Solvent Gradient Purification","volume":"132","author":"De Luca","year":"2020","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.chroma.2022.463487_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ces.2021.117159","article-title":"Integration and digitalization in the manufacturing of therapeutic proteins","volume":"248","author":"Narayanan","year":"2022","journal-title":"Chem. Eng. Sci."},{"key":"10.1016\/j.chroma.2022.463487_bib0017","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jbiotec.2020.07.008","article-title":"Development of an integrated continuous PEGylation and purification process for granulocyte colony stimulating factor","volume":"322","author":"Kateja","year":"2020","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.chroma.2022.463487_bib0018","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.chroma.2013.03.069","article-title":"Online control of the twin-column countercurrent solvent gradient process for biochromatography","volume":"1293","author":"Krattli","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2022.463487_bib0019","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jprocont.2010.02.013","article-title":"Optimizing model predictive control of the chromatographic multi-column solvent gradient purification (MCSGP) process","volume":"20","author":"Grossmann","year":"2010","journal-title":"J. Process Control."},{"key":"10.1016\/j.chroma.2022.463487_bib0020","first-page":"132","article-title":"Modern trends in downstream processing of biotherapeutics through continuous chromatography: the potential of Multicolumn Countercurrent Solvent Gradient Puri fi cation","author":"De Luca","year":"2020","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.chroma.2022.463487_bib0021","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/bit.21529","article-title":"Parametric study of a 6-column countercurrent solvent gradient purification (MCSGP) unit","volume":"98","author":"Aumann","year":"2007","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.chroma.2022.463487_bib0022","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/bit.21527","article-title":"A continuous Multicolumn Countercurrent Solvent Gradient Purification (MCSGP) process","volume":"98","author":"Aumann","year":"2007","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.chroma.2022.463487_bib0023","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/bit.21585","article-title":"A semicontinuous 3-column countercurrent solvent gradient purification (MCSGP) process","volume":"99","author":"Aumann","year":"2008","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.chroma.2022.463487_bib0024","series-title":"Process Intensification in the Manufacturing of Biotherapeutics","first-page":"69","article-title":"Chapter three - application of Multicolumn Countercurrent Solvent Gradient Purification to the polishing of therapeutic proteins","author":"Catani","year":"2022"},{"year":"2018","series-title":"Continuous Biopharmaceutical Processes: Chromatography, Bioconjugation, and Protein Stability","author":"Pfister","key":"10.1016\/j.chroma.2022.463487_bib0025"},{"key":"10.1016\/j.chroma.2022.463487_bib0026","article-title":"Extended MCSGP process for continuous four-fraction separation: case study of monoclonal antibody variants","volume":"241","author":"Muller-Spath","year":"2011","journal-title":"Abstr. Pap. Am. Chem. Soc."},{"key":"10.1016\/j.chroma.2022.463487_bib0027","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/bit.22843","article-title":"Increasing the activity of Monoclonal Antibody Therapeutics by Continuous Chromatography (MCSGP)","volume":"107","author":"Muller-Spath","year":"2010","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.chroma.2022.463487_bib0028","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/bit.22887","article-title":"Two step capture and purification of IgG2 using Multicolumn Countercurrent Solvent Gradient Purification (MCSGP)","volume":"107","author":"Muller-Spath","year":"2010","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.chroma.2022.463487_bib0029","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/bit.21843","article-title":"Chromatographic separation of three monoclonal antibody variants using Multicolumn Countercurrent Solvent Gradient Purification (MCSGP)","volume":"100","author":"Muller-Spath","year":"2008","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.chroma.2022.463487_bib0030","first-page":"1643","article-title":"Using continuous chromatography methodology to achieve high-productivity and high-purity enrichment of charge variants for analytical characterization","author":"Bigelow","year":"2021","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2022.463487_bib0031","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201800677","article-title":"Process for Continuous Fab Production by Digestion of IgG","volume":"14","author":"Ulmer","year":"2019","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.chroma.2022.463487_bib0032","article-title":"Enabling high purities and yields in therapeutic peptide purification using Multicolumn Countercurrent Solvent Gradient Purification","volume":"31","author":"Muller-Spath","year":"2013","journal-title":"Chim. Oggi Chem. Today"},{"key":"10.1016\/j.chroma.2022.463487_bib0033","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1021\/acs.iecr.1c00520","article-title":"Process intensification for the purification of peptidomimetics: the case of icatibant through Multicolumn Countercurrent Solvent Gradient Purification (MCSGP)","volume":"60","author":"De Luca","year":"2021","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.chroma.2022.463487_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26154688","article-title":"Downstream processing of therapeutic peptides by Means of Preparative Liquid Chromatography","volume":"26","author":"De Luca","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.chroma.2022.463487_bib0035","first-page":"46+","article-title":"Protein peptide purification using the Multicolumn Countercurrent Solvent Gradient Purification (MCSGP) process","volume":"22","author":"Aumann","year":"2009","journal-title":"Biopharm. Int."},{"key":"10.1016\/j.chroma.2022.463487_bib0036","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1039\/C5RE00055F","article-title":"A reactive continuous chromatographic process for protein PEGylation","volume":"1","author":"Ingold","year":"2016","journal-title":"React. Chem. Eng."},{"key":"10.1016\/j.chroma.2022.463487_bib0037","first-page":"1663","article-title":"Purification of a GalNAc-cluster-conjugated oligonucleotide by reversed-phase twin-column continuous chromatography","author":"Weldon","year":"2022","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2022.463487_bib0038","unstructured":"Chromacon AG, Application note P2.V2, Purification of a therapeutic oligonucleotide using twin-column chromatography (MCSGP), (2019). 1\u20139. https:\/\/www.chromacon.com\/resources\/public\/lava3\/media\/kcfinder\/files\/Oligonucleotide_MCSGP_application_note.pdf."},{"key":"10.1016\/j.chroma.2022.463487_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2020.460943","article-title":"Design space and robustness analysis of batch and counter-current frontal chromatography processes for the removal of antibody aggregates","volume":"1619","author":"Vogg","year":"2020","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2022.463487_bib0040","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2533\/chimia.2021.476","article-title":"Bachem \u2013 Insights into innovative and sustainable peptide chemistry and technology by the leading independent manufacturer of TIDES","volume":"75","author":"Jadhav","year":"2021","journal-title":"Chimia (Aarau)"},{"key":"10.1016\/j.chroma.2022.463487_bib0041","series-title":"Continuous Biopharmaceutical Processes","first-page":"153","article-title":"Countercurrent chromatography for the polishing steps","author":"Pfister","year":"2018"},{"key":"10.1016\/j.chroma.2022.463487_bib0042","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/bit.24901","article-title":"multifraction separation in countercurrent chromatography (MCSGP)","volume":"110","author":"Kr\u00e4ttli","year":"2013","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.chroma.2022.463487_bib0043","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/btpr.2702","article-title":"Quantitative assessment of environmental impact of biologics manufacturing using process mass intensity analysis","volume":"34","author":"Madabhushi","year":"2018","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.chroma.2022.463487_bib0044","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jbiotec.2019.12.001","article-title":"Economics and ecology: modelling of continuous primary recovery and capture scenarios for recombinant antibody production","volume":"308","author":"Cataldo","year":"2020","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.chroma.2022.463487_bib0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.chroma.2004.09.072","article-title":"Impact of multiple re-use of anion-exchange chromatography media on virus removal","volume":"1069","author":"Norling","year":"2005","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2022.463487_bib0046","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/btpr.2492","article-title":"Integrated continuous bioprocessing: economic, operational, and environmental feasibility for clinical and commercial antibody manufacture","volume":"33","author":"Pollock","year":"2017","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.chroma.2022.463487_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/biot.201700260","article-title":"Monoclonal antibodies production platforms: an opportunity study of a non-protein-a chromatographic platform based on process economics","volume":"12","author":"Grilo","year":"2017","journal-title":"Biotechnol. J."}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967322006793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967322006793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T06:19:23Z","timestamp":1758262763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967322006793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":47,"alternative-id":["S0021967322006793"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2022.463487","relation":{},"ISSN":["0021-9673"],"issn-type":[{"type":"print","value":"0021-9673"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and economic investigation of a Multicolumn Countercurrent Solvent Gradient Purification unit for the separation of an industrially relevant PEGylated protein","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2022.463487","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"463487"}}